The clinical application of abciximab combined with mechanical distal protection (PercuSurge or FilterWire Ex) was described for feasibility and technical limitations in 34 cases of acute myocardial infarction.
Observational (n=34)
No
This single-center case series describes the feasibility and technical considerations of using mechanical distal protection devices alongside abciximab during primary PCI for acute myocardial infarction.
Distal embolization of plaque or thrombotic debris is one of the mechanisms involved in the ischemia/reperfusion injury during primary percutaneous intervention for acute occlusion of a native coronary artery. We tested the clinical application of maximal antiplatelet therapy with abciximab combined with one of two different systems of mechanical distal protection: balloon occlusion and aspiration (PercuSurge) in 24 cases and a distal filter (FilterWire Ex) in 10 cases. Feasibility, technical limitations, and pitfalls are described.
Orrego et al. (Tue,) conducted a observational in Acute myocardial infarction (n=34). Abciximab combined with mechanical distal protection (PercuSurge or FilterWire Ex) was evaluated on Feasibility, technical limitations, and pitfalls. The clinical application of abciximab combined with mechanical distal protection (PercuSurge or FilterWire Ex) was described for feasibility and technical limitations in 34 cases of acute myocardial infarction.